![PDF) KOMET: An unblinded, randomised, two parallelgroup, stratified trial comparing the effectiveness of levetiracetam with controlled-release carbamazepine and extended-release sodium valproate as monotherapy in patients with newly diagnosed epilepsy PDF) KOMET: An unblinded, randomised, two parallelgroup, stratified trial comparing the effectiveness of levetiracetam with controlled-release carbamazepine and extended-release sodium valproate as monotherapy in patients with newly diagnosed epilepsy](https://i1.rgstatic.net/publication/230763604_KOMET_An_unblinded_randomised_two_parallelgroup_stratified_trial_comparing_the_effectiveness_of_levetiracetam_with_controlled-release_carbamazepine_and_extended-release_sodium_valproate_as_monotherapy/links/00b7d52ad64dc771b0000000/largepreview.png)
PDF) KOMET: An unblinded, randomised, two parallelgroup, stratified trial comparing the effectiveness of levetiracetam with controlled-release carbamazepine and extended-release sodium valproate as monotherapy in patients with newly diagnosed epilepsy
Discovery of the Novel Antithrombotic Agent 5-Chloro-N-({(5S)-2-oxo-3- [4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene- 2-carboxamide (BAY 59-7939): An Oral, Direct Factor Xa Inhibitor | Journal of Medicinal Chemistry
![PDF) Chronic Toxoplasma infection is associated with distinct alterations in the synaptic protein composition PDF) Chronic Toxoplasma infection is associated with distinct alterations in the synaptic protein composition](https://i1.rgstatic.net/publication/326755583_Chronic_Toxoplasma_infection_is_associated_with_distinct_alterations_in_the_synaptic_protein_composition/links/5b72ca3492851ca6505d5e05/largepreview.png)